Clever Leaves Holdings Inc (CLVR)
2.90
-0.10
(-3.33%)
USD |
OTCM |
May 23, 15:42
Clever Leaves Holdings Cash from Investing (Quarterly): 2.056M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.056M |
September 30, 2023 | 2.717M |
June 30, 2023 | -0.044M |
March 31, 2023 | -0.035M |
December 31, 2022 | 0.55M |
September 30, 2022 | -0.255M |
June 30, 2022 | 2.112M |
March 31, 2022 | -1.215M |
December 31, 2021 | -1.332M |
September 30, 2021 | -1.629M |
June 30, 2021 | -2.103M |
March 31, 2021 | -2.216M |
Date | Value |
---|---|
December 31, 2020 | -0.379M |
September 30, 2020 | 0.15M |
June 30, 2020 | -1.781M |
March 31, 2020 | -1.655M |
March 31, 2018 | 0.9947M |
September 30, 2017 | -0.0997M |
June 30, 2017 | 1.957M |
March 31, 2017 | 0.1353M |
September 30, 2016 | 7.232M |
June 30, 2016 | 0.0714M |
March 31, 2016 | -0.1103M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.216M
Minimum
Mar 2021
2.717M
Maximum
Sep 2023
-0.3162M
Average
-0.317M
Median
Cash from Investing (Quarterly) Benchmarks
Tilray Brands Inc | 28.09M |
Flora Growth Corp | -0.088M |
Acasti Pharma Inc | -6.554M |
Aurinia Pharmaceuticals Inc | -6.257M |
Edesa Biotech Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.543M |
Cash from Financing (Quarterly) | -0.162M |
Free Cash Flow | -11.54M |
Free Cash Flow Per Share (Quarterly) | -0.8019 |
Free Cash Flow to Equity (Quarterly) | -1.269M |
Free Cash Flow to Firm (Quarterly) | -1.364M |
Free Cash Flow Yield | -253.9% |